How a Drug Company Made $114 Billion by Gaming the U.S. Patent System
AbbVie for years delayed competition for its blockbuster drug Humira, at the expense of patients and taxpayers. The monopoly is about to end.
AbbVie for years delayed competition for its blockbuster drug Humira, at the expense of patients and taxpayers. The monopoly is about to end.
Growing research has shown that intensive interventions are needed, scientists say. Here is why their advice is changing.
New York-based Paradigm has raised a significant amount to simplify clinical trials. Its goal is ambitious, but its challenges are many, researchers say.
As advisers to the Food and Drug Administration endorsed ending one era of the Covid vaccination campaign, they also grappled with its future.
Las personas que usan medicamentos como Ozempic están encontrando un efecto secundario no deseado: envejecimiento facial.
Hody Childress brought cash every month to a pharmacist in Alabama, asking her to use it to help people buy medicine. The town learned of the arrangement only after his death.
The case, brought by GenBioPro, a company that makes one of two abortion drugs, argues that it is unconstitutional for a state to bar access to a medication approved by the federal government.
People using drugs like Ozempic are discovering an unwanted side affect: facial aging.
People using drugs like Ozempic are discovering an unwanted side affect: facial aging.
A wave of transformative but hugely expensive treatments is challenging the budgets of health systems in wealthy nations. Now countries with far fewer resources are wrestling with how to cover the therapies.